CDC: Self-Administered Subcutaneous DMPA Should Be Made Available

FRIDAY, May 21, 2021 -- Self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) should be made available as an additional approach for contraception, according to research published in the May 21 issue of the U.S. Centers for...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news